MUPIROCIN LITHIUM (100 MG)H0C176926UG/MG(AI)
Synonym(s):9-((E)-4-{(2S,3R,4R,5S)-3,4-Dihydroxy-5-[(2S,3S)-3-((1S,2S)-2-hydroxy-1-methyl-propyl)oxiranylmethyl]tetrahydro-pyran-2-yl}-3-methyl-but-2-enoyloxy)nonanoic acid lithium salt;Li-MUP;Lithium mupirocin solution;MUP supplement;Pseudomonic acid A lithium salt
- CAS NO.：73346-79-9
- Empirical Formula: C26H43O9.Li
- Molecular Weight: 506.558
- MDL number: MFCD11977847
- EINECS: 815-147-3
- SAFETY DATA SHEET (SDS)
- Update Date: 2023-05-18 11:31:16
What is MUPIROCIN LITHIUM (100 MG)H0C176926UG/MG(AI)?
The Uses of MUPIROCIN LITHIUM (100 MG)H0C176926UG/MG(AI)
Mupirocin Lithium is a major component of the pseudomonic acid, an antibiotic complex produced by Pseudomonas fluorescens NCIB 10586. Topical antibacterial.
The Uses of MUPIROCIN LITHIUM (100 MG)H0C176926UG/MG(AI)
Lithium mupirocin as been used to study mupirocin resistance in staphylococcus aureus and in mycoplasma susceptibility studies .
Properties of MUPIROCIN LITHIUM (100 MG)H0C176926UG/MG(AI)
| storage temp. | 2-8°C |
| solubility | H2O: soluble10mg/mL, clear, colorless |
| form | powder |
| color | colorless or white |
| optical activity | [α]/D -21.0±2.0°, c = 1 in H2O |
| Water Solubility | Soluble in water at approximately 10mg/ml |
| Stability: | Hygroscopic |
Safety information for MUPIROCIN LITHIUM (100 MG)H0C176926UG/MG(AI)
| Signal word | Warning |
| Pictogram(s) |
 Exclamation Mark Irritant GHS07 |
| GHS Hazard Statements |
H315:Skin corrosion/irritation H319:Serious eye damage/eye irritation H335:Specific target organ toxicity, single exposure;Respiratory tract irritation |
| Precautionary Statement Codes |
P261:Avoid breathing dust/fume/gas/mist/vapours/spray. P271:Use only outdoors or in a well-ventilated area. P280:Wear protective gloves/protective clothing/eye protection/face protection. |
Computed Descriptors for MUPIROCIN LITHIUM (100 MG)H0C176926UG/MG(AI)
New Products
4-AMINO-TETRAHYDRO-PYRAN-4-CARBOXYLIC ACID HCL 4-(Dimethylamino)tetrahydro-2H-pyran-4-carbonitrile 4-Aminotetrahydropyran-4-carbonitrile Hydrochloride (R)-3-Aminobutanenitrile Hydrochloride 3-((Dimethylamino)methyl)-5-methylhexan-2-one oxalate 1,4-Dioxa-8-azaspiro[4.5]decane 5-Bromo-2-nitropyridine Nimesulide BP Aceclofenac IP/BP/EP Diclofenac Sodium IP/BP/EP/USP Mefenamic Acid IP/BP/EP/USP Ornidazole IP Diclofenac Potassium THOMAIND PAPER PH 2.0 TO 4.5 1 BOX BUFFER CAPSULE PH 9.2 - 10 CAP SODIUM CHLORIDE 0.1N CVS ALLOXAN MONOHYDRATE 98% PLATINUM 0.5% ON 3 MM ALUMINA PELLETS (TYPE 73) LITHIUM AAS SOLUTION 2-Bromo-1-(bromomethyl)-3-chloro-5-nitrobenzene 2-Bromo-3-nitroaniline N-(3-Hydroxypropyl)-N-methylacetamide 3-Bromo-6-chloropyridazine 4-ethyl-3-nitrobenzoic acidRelated products of tetrahydrofuran
![4H-Furo[2,3-c]pyranyl Mupirocin SodiuM IMpurity](https://img.chemicalbook.in/CAS/GIF/116182-43-5.gif)
![9-[[(2E)-4-[[(2S,3R,4R,5S)-3α,4α-Dihydroxy-5β-[(2E,4S,5S)-5-hydroxy-4-methyl-2-hexenyl]tetrahydro-2H-pyran]-2β-yl]-3-methyl-2-butenoyl]oxy]nonanoic acid](https://img.chemicalbook.in/CAS/20210111/GIF/71980-98-8.gif)
You may like
-
Lithium mupirocin CAS 73346-79-9View Details
73346-79-9 -
1-Methyl-6-oxo-1,6-dihydropyridazine-3-carbonitrile 98%View Details
99903-60-3 -
1823368-42-8 98%View Details
1823368-42-8 -
2-(3-(tert-butyl)phenoxy)-2-methylpropanoic acid 1307449-08-6 98%View Details
1307449-08-6 -
Ethyl 3-(furan-2-yl)-3-hydroxypropanoate 25408-95-1 98%View Details
25408-95-1 -
2-Chloro-5-fluoro-1-methoxy-3-methylbenzene 98%View Details
1805639-70-6 -
1784294-80-9 98%View Details
1784294-80-9 -
Lithium ClavulanateView Details
61177-44-4
Statement: All products displayed on this website are only used for non medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.